Closed-loop insulin delivery: update on the state of the field and emerging technologies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Closed-loop insulin delivery: update on the state of the field and emerging technologies
Authors
Keywords
-
Journal
Expert Review of Medical Devices
Volume 19, Issue 11, Pages 859-875
Publisher
Informa UK Limited
Online
2022-11-04
DOI
10.1080/17434440.2022.2142556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GLP ‐1 Receptor Agonists as Adjunctive Treatment for Type 1 Diabetes: Renewed Opportunities through Tailored Approaches?
- (2022) Alessandra Kobayati et al. DIABETES OBESITY & METABOLISM
- The beneficial effects of closed‐loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU‐WP10 trial
- (2022) Pierre‐Yves Benhamou et al. DIABETES OBESITY & METABOLISM
- Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes
- (2022) Julia Ware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands
- (2022) Erik H. Serné et al. ADVANCES IN THERAPY
- In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial
- (2022) Thekla Berge et al. DIABETES OBESITY & METABOLISM
- Feasibility study of a prototype extended‐wear insulin infusion set in adults with type 1 diabetes
- (2022) Jasmin R. Kastner et al. DIABETES OBESITY & METABOLISM
- Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users
- (2022) Arcelia Arrieta et al. DIABETES OBESITY & METABOLISM
- Parents’ experiences of using a hybrid closed-loop system (CamAPS FX) to care for a very young child with type 1 diabetes: Qualitative study
- (2022) Barbara Kimbell et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
- (2022) Ron Brazg et al. Diabetes Technology & Therapeutics
- Dynamics of HbA1c, BMI and rates of severe hypoglycemia in 4,434 adults with type 1 or type 2 diabetes after initiation of continuous glucose monitoring
- (2022) Stefanie Lanzinger et al. Diabetes Technology & Therapeutics
- Real‐world prospective observational single‐centre study: Hybrid closed loop improves HbA1c, time‐in‐range and quality of life for children, young people and their carers
- (2022) Sze May Ng et al. DIABETIC MEDICINE
- Parents’ experiences of using remote monitoring technology to manage type 1 diabetes in very young children during a clinical trial: Qualitative study
- (2022) Ruth I. Hart et al. DIABETIC MEDICINE
- Parents' views about healthcare professionals having real‐time remote access to their young child's diabetes data: Qualitative study
- (2022) Barbara Kimbell et al. PEDIATRIC DIABETES
- Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial
- (2022) Jennifer L. Sherr et al. DIABETES CARE
- The Cost of Control: Cost-Effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth
- (2022) Anthony Pease et al. DIABETES CARE
- Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents
- (2022) Korey K. Hood et al. DIABETES OBESITY & METABOLISM
- Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up
- (2021) Coralie Amadou et al. DIABETES CARE
- Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control
- (2021) Erin Cobry et al. Diabetes Technology & Therapeutics
- A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
- (2021) Richard M Bergenstal et al. LANCET
- Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes
- (2021) Olivia J. Collyns et al. DIABETES CARE
- Reducing the need for carbohydrate counting in type 1 diabetes using closed‐loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non‐inferiority, crossover pilot trial
- (2021) Ahmad Haidar et al. DIABETES OBESITY & METABOLISM
- Hybrid closed‐loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double‐blind, multicentre, multinational, randomized, crossover study
- (2021) Charlotte K. Boughton et al. DIABETES OBESITY & METABOLISM
- Data sharing whilst using a closed-loop system: Qualitative study of adolescents’ and parents’ experiences and views
- (2021) Julia Lawton et al. Diabetes Technology & Therapeutics
- New closed-loop insulin systems
- (2021) Charlotte K. Boughton et al. DIABETOLOGIA
- Transforming type 1 diabetes: the next wave of innovation
- (2021) Daniel J. Drucker DIABETOLOGIA
- Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
- (2021) Luz E. Castellanos et al. DIABETES CARE
- Longevity of the novel ConvaTec infusion set with Lantern technology
- (2021) Rayhan A. Lal et al. DIABETES OBESITY & METABOLISM
- One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
- (2021) Marc D. Breton et al. Diabetes Technology & Therapeutics
- Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial
- (2021) Tadej Battelino et al. PEDIATRIC DIABETES
- Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes
- (2021) Julia Fuchs et al. Frontiers in Pediatrics
- Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial
- (2021) Melissa H. Lee et al. DIABETES CARE
- Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
- (2021) Sue A. Brown et al. DIABETES CARE
- Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry
- (2021) Nudrat Noor et al. DIABETES CARE
- Patient Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed Loop Trial
- (2021) Yogish C. Kudva et al. Diabetes Technology & Therapeutics
- Lived experience of advanced hybrid closed-loop versus hybrid closed loop: patient-reported outcomes and perspectives
- (2021) Korey Hood et al. Diabetes Technology & Therapeutics
- Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users
- (2021) Julien Da Silva et al. Diabetes Technology & Therapeutics
- Closed‐loop technology: a practical guide
- (2021) Sara Hartnell et al. Practical Diabetes
- Inequities in Health Outcomes in Children and Adults With Type 1 Diabetes: Data From the T1D Exchange Quality Improvement Collaborative
- (2021) Shideh Majidi et al. Clinical Diabetes
- Adolescents’ Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study
- (2021) David Rankin et al. Journal of diabetes science and technology
- Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial
- (2021) Sybil A. McAuley et al. DIABETES CARE
- Outcomes of hybrid closed‐loop insulin delivery activated 24/7 versus evening and night in free‐living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial
- (2021) Eric Renard et al. DIABETES OBESITY & METABOLISM
- Cost-effectiveness analysis of an Advanced Hybrid Closed Loop insulin delivery system in people with type 1 diabetes in Greece
- (2021) Vaia Lambadiari et al. Diabetes Technology & Therapeutics
- Current provision and HCP experiences of remote care delivery and diabetes technology training for people with type 1 diabetes in the UK during the COVID‐19 pandemic
- (2021) Hannah Forde et al. DIABETIC MEDICINE
- Real‐world evidence on clinical outcomes of people with type 1 diabetes using open‐source and commercial automated insulin dosing systems: A systematic review
- (2021) Christine Knoll et al. DIABETIC MEDICINE
- Recent advances in closed-loop insulin delivery
- (2021) Julia Ware et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Safe and effective use of a hybrid closed‐loop system from diagnosis in children under 18 months with type 1 diabetes
- (2021) Xanthippi Tseretopoulou et al. PEDIATRIC DIABETES
- Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes
- (2021) Mary B. Abraham et al. JAMA Pediatrics
- The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden
- (2021) Johan Jendle et al. Diabetes Therapy
- A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial
- (2020) Ahmad Haidar et al. DIABETES CARE
- Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry
- (2020) Martin Tauschmann et al. DIABETES CARE
- What training, support and resourcing do health professionals need to support people using a closed-loop system? A qualitative interview study with health professionals involved in the Closed Loop from Onset in type 1 Diabetes (CLOuD) trial
- (2020) Barbara Kimbell et al. Diabetes Technology & Therapeutics
- Health professionals' views about who would benefit from using a closed‐loop system: a qualitative study
- (2020) J. Lawton et al. DIABETIC MEDICINE
- Cost-effectiveness analysis of a hybrid closed-loop system versus multiple daily injections and capillary glucose testing for adults with type 1 diabetes.
- (2020) Anthony James Pease et al. Diabetes Technology & Therapeutics
- Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: The MILLENNIAL Study
- (2020) Hood Thabit et al. DIABETES CARE
- Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy
- (2020) Julia Fuchs et al. Expert Review of Medical Devices
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes
- (2020) Lori M. Laffel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review
- (2020) F. Andreozzi et al. Diabetology & Metabolic Syndrome
- A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison
- (2020) Ananta Addala et al. DIABETES CARE
- Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial
- (2020) Sybil A. McAuley et al. DIABETES CARE
- Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
- (2020) Jordan E. Pinsker et al. Diabetes Technology & Therapeutics
- A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
- (2020) Marc D. Breton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes
- (2020) Lauren G. Kanapka et al. DIABETES CARE
- Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study
- (2020) Torben Biester et al. DIABETES OBESITY & METABOLISM
- A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System
- (2020) John Lum et al. Diabetes Technology & Therapeutics
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
- (2019) Charlotte K Boughton et al. Lancet Diabetes & Endocrinology
- Fully closed-loop insulin delivery Improves glucose control of inpatients with type 2 diabetes receiving hemodialysis
- (2019) Lia Bally et al. KIDNEY INTERNATIONAL
- A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm
- (2019) Laurel H. Messer et al. Diabetes Technology & Therapeutics
- Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
- (2019) Colette Mair et al. DIABETOLOGIA
- Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery
- (2019) Klemen Dovc et al. DIABETES CARE
- Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes
- (2019) Rayhan A Lal et al. ENDOCRINE REVIEWS
- One Year Clinical Experience of the First Commercial Hybrid Closed-Loop
- (2019) Rayhan A. Lal et al. DIABETES CARE
- Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial
- (2019) Klemen Dovc et al. DIABETES CARE
- WITHDRAWN: IDF Diabetes Atlas: Worldwide Estimates of Incidence, Prevalence and Mortality of Type 1 Diabetes in Children and Adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Christopher C. Patterson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Transatlantic HbA1c gap: differences in glycaemic control across the life‐span between the US T1D Exchange and German/Austrian DPV registries
- (2019) Julia M. Hermann et al. DIABETIC MEDICINE
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of Diabetes Technology
- (2019) Klemen Dovc et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system
- (2019) Cari Berget et al. PEDIATRIC DIABETES
- Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial
- (2018) Zoe A. Stewart et al. DIABETES CARE
- Adaptability of Closed Loop During Labor, Delivery, and Postpartum: A Secondary Analysis of Data from Two Randomized Crossover Trials in Type 1 Diabetes Pregnancy
- (2018) Zoe A. Stewart et al. Diabetes Technology & Therapeutics
- Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems
- (2018) T. M. Peters et al. DIABETIC MEDICINE
- Technology in the management of type 1 diabetes mellitus — current status and future prospects
- (2018) Martin Tauschmann et al. Nature Reviews Endocrinology
- Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial
- (2018) Gregory P. Forlenza et al. DIABETES CARE
- Is insulin pump therapy effective in Type 1 diabetes?
- (2018) J. C. Pickup DIABETIC MEDICINE
- Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
- (2018) Martin Tauschmann et al. LANCET
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
- (2017) Marcus Lind et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
- (2017) Roy W. Beck et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
- (2017) Firas H El-Khatib et al. LANCET
- Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
- (2017) Alanna Weisman et al. Lancet Diabetes & Endocrinology
- Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type
- (2016) P Ross et al. ACTA DIABETOLOGICA
- Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population
- (2016) DIABETES CARE
- Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report: Table 1
- (2016) David M. Maahs et al. DIABETES CARE
- Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes
- (2016) Zoe A. Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial
- (2016) Steven J Russell et al. Lancet Diabetes & Endocrinology
- Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs
- (2015) Lutz Heinemann et al. DIABETES CARE
- 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial
- (2015) Jort Kropff et al. Lancet Diabetes & Endocrinology
- MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover Trial
- (2014) Revital Nimri et al. DIABETES CARE
- Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
- (2014) Roman Hovorka et al. DIABETES CARE
- Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
- (2014) Steven J. Russell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes
- (2013) J. L. Sherr et al. DIABETES CARE
- Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey
- (2013) John C. Pickup et al. Diabetes Technology & Therapeutics
- Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
- (2013) Moshe Phillip et al. NEW ENGLAND JOURNAL OF MEDICINE
- Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia
- (2013) Richard M. Bergenstal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
- (2012) D. Elleri et al. DIABETES CARE
- Patient Time Costs Associated with Sensor-Augmented Insulin Pump Therapy for Type 1 Diabetes
- (2012) Shital Kamble et al. MEDICAL DECISION MAKING
- Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study
- (2011) Robert H. Slover et al. PEDIATRIC DIABETES
- MD-Logic Artificial Pancreas System: A pilot study in adults with type 1 diabetes
- (2010) E. Atlas et al. DIABETES CARE
- Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment
- (2010) O. Kordonouri et al. DIABETOLOGIA
- Etiology of Type 1 Diabetes
- (2010) John A. Todd IMMUNITY
- Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial
- (2010) Roman Hovorka et al. LANCET
- Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study
- (2009) D. Raccah et al. DIABETES CARE
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas
- (2008) S. A. Weinzimer et al. DIABETES CARE
- Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study
- (2008) Irl B. Hirsch et al. Diabetes Technology & Therapeutics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started